(Q34464750)

2 August 2017

title

Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition (English)

1 reference

2 August 2017

Fowler JS

1

1 reference

2 August 2017

Volkow ND

2

1 reference

2 August 2017

Wang GJ

3

1 reference

2 August 2017

Pappas N

4

1 reference

2 August 2017

Logan J

5

1 reference

2 August 2017

MacGregor R

6

1 reference

2 August 2017

Alexoff D

7

1 reference

2 August 2017

Wolf AP

8

1 reference

2 August 2017

Warner D

9

1 reference

2 August 2017

Cilento R

10

1 reference

2 August 2017

Zezulkova I

11

1 reference

2 August 2017

publication date

1 January 1998

1 reference

Journal of Addictive Diseases

2 August 2017

published in

1 reference

2 August 2017

volume

17

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

23-34

1 reference

Addictive Drugs: The Cigarette Experience

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Cigarette smoking and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Smoking, smoking cessation, and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Involvement of tobacco in alcoholism and illicit drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Monoamine oxidase B, smoking, and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Irreversible inhibition of monoamine oxidase by some components of cigarette smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Inhibition of monoamine oxidase B in the brains of smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Plasma input function determination for PET using a commercial laboratory robot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Effects of endogenous dopamine on measures of [18F]N-methylspiroperidol binding in the basal ganglia: Comparison of simulations and experimental results from PET studies in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: the degree and reversibility of human brain MAO B inhibition by Ro 19 6327.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

On the construction of functional maps in positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Dopamine is a monoamine oxidase B substrate in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Aging and Extrapyramidal Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

The effect of deprenyl (selegiline) on the natural history of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V17N01_03

21 January 2018

Identifiers

DOI

10.1300/J069V17N01_03

1 reference

2 August 2017

1 reference